Cargando…
Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
Receptor tyrosine kinase ROR1, an embryonic protein involved in organogenesis, is expressed in certain hematological malignancies and solid tumors, but is generally absent in adult tissues. This makes the protein an ideal drug target for cancer therapy. In order to assess the suitability of ROR1 as...
Autores principales: | Liu, Yanchun, Yang, Hui, Chen, Tianxing, Luo, Yongbin, Xu, Zheyuan, Li, Ying, Yang, Jiahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433279/ https://www.ncbi.nlm.nih.gov/pubmed/25978653 http://dx.doi.org/10.1371/journal.pone.0127092 |
Ejemplares similares
-
Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
por: Ghareghomi, Somayyeh, et al.
Publicado: (2023) -
Silencing of CPSF7 inhibits the proliferation, migration, and invasion of lung adenocarcinoma cells by blocking the AKT/mTOR signaling pathway
por: An, Weishao, et al.
Publicado: (2022) -
PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011) -
Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma
por: Zhang, Kexiang, et al.
Publicado: (2021) -
Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway
por: Hu, Wei, et al.
Publicado: (2023)